David Murdoch | |
---|---|
9th Vice-Chancellor of the University of Otago | |
In office February 2022 –June 2023 | |
Chancellor | Stephen Higgs |
Preceded by | Harlene Hayne |
Succeeded by | Grant Robertson |
Personal details | |
Born | Dunedin,New Zealand | 10 July 1962
Awards | Distinguished Research Medal (2020) Outstanding Leadership Award (2020) |
Academic background | |
Alma mater | University of Otago |
Thesis | Diagnosis of legionella infection:role of PCR and other techniques for testing non-respiratory samples (2003) |
Academic work | |
Discipline | paediatric infectious diseases |
David R. Murdoch (born 10 July 1962) is a New Zealand academic specialising in paediatric infectious diseases,especially pneumonia. He has also worked on Legionnaires' disease and has advised the Oxford University vaccine group and the New Zealand government on COVID-19. Murdoch served as Vice-Chancellor of the University of Otago between February 2022 and June 2023. [1]
Murdoch was born in Dunedin in 1962,and was educated at Ōpoho Primary School,before moving to Christchurch at six years old. [2] Murdoch graduated from the University of Otago in 1985 with a Bachelor of Medicine and Bachelor of Surgery. [2]
Murdoch also holds a Doctorate in Medicine from the University of Otago,completed in 2003,a Master of Science in Epidemiology from the University of London,a Diploma in Tropical Medicine and Hygiene from the University of Liverpool and a Diploma from the London School of Hygiene and Tropical Medicine. [3]
Murdoch became interested in childhood infectious diseases after a trip to Nepal,working in one of Sir Edmund Hillary's mountain hospitals,where he saw the effects of measles on the local population. [4] His work on Legionnaires' disease led to the establishment of a New Zealand-wide surveillance system. [4]
Murdoch led a Bill and Melinda Gates Foundation-funded global study of childhood pneumonia,which changed the way the disease is diagnosed,and led to new treatments and preventative measures in developing countries. Murdoch is co-director of the One Health Aotearoa research alliance,which is a group of infectious disease experts from the University of Otago's medical school,Massey University's veterinary school and the Institute of Environmental Science and Research (ESR),who are working together to address health hazards across the human,animal and environmental interfaces. [2]
Murdoch was one of three international experts advising Oxford University on its vaccine against COVID19. [5]
He was Head of Pathology in Christchurch for 14 years,including the period after the Canterbury earthquakes. He was appointed Dean of the University of Otago,Christchurch in 2016. [6] In July 2021 it was announced that Murdoch will take over the role of Vice-Chancellor of the University of Otago from acting Vice-Chancellor Helen Nicholson in early 2022. [2]
Murdoch began his tenure in February 2022 and announced that "creating change" would be his "highest priority" following a review into allegations of racism at the School of Physical Education,Sport and Exercise Sciences. Under his leadership,Otago University embarked on a proposal to change its logo with its coat of arms replaced by a Māori cultural symbol tohu and a new Māori name for the university. In March 2023,Murdoch went on sick leave with Dr. Helen Nicholson taking over as acting-Vice Chancellor. In mid-June 2023,Murdoch resigned as Vice-Chancellor of the University of Otago,roughly 18 months after assuming the job. [1] Murdoch will return to Otago's Canterbury campus as a distinguished professor. [7]
Murdoch received the University of Otago's Distinguished Research Medal in 2020. [4] He also won the Outstanding Leadership Award at the university in 2020. [2]
Murdoch is a Fellow of the Royal Australasian College of Physicians (infectious diseases),and also of the Royal College of Pathologists of Australasia. In 2005 he was made a Fellow of the Infectious Diseases Society of America,and in 2019 he was made a Fellow of the American Academy of Microbiology. [2]
Murdoch was made an Honorary life member of the Himalayan Rescue Association of Nepal in 1988,and an Honorary member of the Holistic Health Society –Nepal,for "outstanding service and contribution in the health sector of Nepal" in 2017. [2]
Pneumonia is an inflammatory condition of the lung primarily affecting the small air sacs known as alveoli. Symptoms typically include some combination of productive or dry cough, chest pain, fever, and difficulty breathing. The severity of the condition is variable.
Pontiac fever is an acute, nonfatal respiratory disease caused by various species of Gram-negative bacteria in the genus Legionella. It causes a mild upper respiratory infection that resembles acute influenza. Pontiac fever resolves spontaneously and often goes undiagnosed. Both Pontiac fever and the more severe Legionnaire's disease may be caused by the same bacteria, but Pontiac fever does not include pneumonia.
The University of Otago is a public research collegiate university based in Dunedin, Otago, New Zealand. Founded in 1869, Otago is New Zealand's oldest university and one of the oldest universities in Oceania.
Legionella is a genus of pathogenic gram-negative bacteria that includes the species L. pneumophila, causing legionellosis including a pneumonia-type illness called Legionnaires' disease and a mild flu-like illness called Pontiac fever.
Sir Peter Karel, Baron Piot, is a Belgian-British microbiologist known for his research into Ebola and AIDS.
The University of Otago, Christchurch is one of seven component schools that make up the University of Otago Division of Health Sciences. The University of Otago, Christchurch is based primarily at Christchurch Hospital, in Christchurch Central City, and works in partnership with the Canterbury District Health Board.
Pneumonia is a common respiratory infection, affecting approximately 450 million people a year and occurring in all parts of the world. It is a major cause of death among all age groups, resulting in 1.4 million deaths in 2010 and 3.0 million deaths in 2016.
Vada Harlene Hayne is an American-born academic administrator who was the vice-chancellor and a professor of psychology at the University of Otago in New Zealand, before moving to Western Australia to take up the position of vice-chancellor at Curtin University in April 2021.
Legionnaires' disease is a form of atypical pneumonia caused by any species of Legionella bacteria, quite often Legionella pneumophila. Signs and symptoms include cough, shortness of breath, high fever, muscle pains, and headaches. Nausea, vomiting, and diarrhea may also occur. This often begins 2–10 days after exposure.
Helen Nicholson is a New Zealand medical academic specialising in male reproductive health. She is a full professor and served as Acting Vice-Chancellor of the University of Otago between March 2023 and June 2024.
John Andrew Crump MB ChB, MD, DTM&H, FRACP, FRCPA, FRCP is a New Zealand-born infectious diseases physician, medical microbiologist, and epidemiologist. He is Professor of Medicine, Pathology, and Global Health at the University of Otago and an adjunct professor of medicine, Pathology, and Global Health at Duke University. He served as inaugural co-director of the Otago Global Health Institute, one of the university's research centres. His primary research interest is fever in the tropics, focusing on invasive bacterial diseases and bacterial zoonoses.
Suzanne Georgina Pitama is a New Zealand academic, is Māori, of Ngāti Kahungunu and Ngāti Whare descent and as of 2020 is a full professor at the University of Otago in Christchurch, New Zealand.
Lidia Morawska is a Polish–Australian physicist and distinguished professor at the School of Earth and Atmospheric Sciences, at the Queensland University of Technology and director of the International Laboratory for Air Quality and Health (ILAQH) at QUT. She is also co-director of the Australia-China Centre for Air Quality Science and Management, an adjunct professor at the Jinan University in China, and a Vice-Chancellor fellow at the Global Centre for Clean Air Research (GCARE), University of Surrey in the United Kingdom. Her work focuses on fundamental and applied research in the interdisciplinary field of air quality and its impact on human health, with a specific focus on atmospheric fine, ultrafine and nanoparticles. Since 2003, she expanded her interests to include also particles from human respiration activities and airborne infection transmission.
Diana Rae Martin was a New Zealand microbiologist. She was a Fellow of the Royal Society Te Apārangi from 2000, and was made an Officer of the New Zealand Order of Merit for services to microbiology in 2008.
Tania Sorrell is an Australian infectious disease physician who is a Professor and Director of the Marie Bashir Institute for Infectious Diseases and Biosecurity at the University of Sydney. She serves as Chair of the National Health and Medical Research Council Research Translation Faculty Steering Group on New and Emerging Health Threats. She is interested in the diagnosis, prevention and treatment of infectious diseases.
George Ian TownFRACP is a New Zealand respiratory scientist and health official. He was appointed the Chief Science Advisor to the New Zealand Ministry of Health in 2019.
The 2022 Tucumán legionellosis outbreak refers to an epidemic that originated in San Miguel de Tucumán, Argentina. It was first identified on Saturday, 20 August 2022, when 7 people arrived at the Tucumán Hospital with fever, malaise, shortness of breath, and headache.
Patricia Priest is a New Zealand public health scientist and epidemiologist who is Professor of Public Health in Medicine at the University of Otago. Throughout the COVID-19 pandemic, Priest served as an advisor to the New Zealand Ministry of Health. She was awarded an Ig Nobel Prize in 2010. As of 2024 Priest is the Acting Pro-Vice-Chancellor of the Division of Health Sciences at the university.
Rosalina Richards is a Samoan New Zealand behavioural psychologist, and is a full professor at the University of Otago, specialising in Pacific public health.
Catherine Ann Malcolm Stedman is a New Zealand pharmacologist and gastroenterologist, and is a clinical professor at the University of Otago, specialising in hepatitis C drug development. She is the first woman gastroenterologist to become a professor of medicine in New Zealand.